Patent: 6,013,620
✉ Email this page to a colleague
Summary for Patent: 6,013,620
Title: | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
Abstract: | The invention relates to a pharmaceutical composition for the treatment of patients with blood coagulation diseases which are caused by coagulation factor deficiency and/or inhibitors of coagulation factors, whereby the composition as a FEIB-activity and is characterized in that it has Factor VIIa and at least one further active ingredient and the activity of at least 10 Factor VIIa units per unit FEIBA. Additionally, the invention comprises a method for the production of the pharmaceutical preparation and its use. |
Inventor(s): | Turecek; Peter (Klosterneuburg, AT), Schwarz; Hans-Peter (Vienna, AT), Redl; Gerda (Rutzendorf, AT) |
Assignee: | Baxter Aktiengesellschaft (Vienna, AT) |
Application Number: | 08/926,845 |
Patent Claims: | see list of patent claims |
Details for Patent 6,013,620
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 12/21/1979 | ⤷ Try a Trial | 2015-08-28 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 07/31/2000 | ⤷ Try a Trial | 2015-08-28 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 08/11/2005 | ⤷ Try a Trial | 2015-08-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |